EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (Form S-3) and related Prospectuses of Evoke Pharma, Inc. for the registration of up to $100,000,000 in aggregate principal amount of Evoke Pharma, Inc.’s common stock, preferred stock, debt securities, warrants and/or units and to the incorporation by reference therein of our report dated March 25, 2014, with respect to the financial statements of Evoke Pharma, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2013, filed with the Securities and Exchange Commission.
| /s/ Ernst & Young LLP |
San Diego, California
November 13, 2014
